Roche
RO.SW
#41
Rank
NZ$600.34 B
Marketcap
NZ$754.56
Share price
-0.29%
Change (1 day)
36.58%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2025: NZ$35.78

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$35.78. In 2025 the company made an earnings per share (EPS) of NZ$35.78 an increase over its 2024 EPS that were of NZ$20.14.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025NZ$35.7877.67%
2024NZ$20.14-32.84%
2023NZ$29.981.95%
2022NZ$29.41-6.29%
2021NZ$31.38-5.53%
2020NZ$33.2216.56%
2019NZ$28.5030.3%
2018NZ$21.8720.22%
2017NZ$18.20-5.81%
2016NZ$19.324.62%
2015NZ$18.46-5.13%
2014NZ$19.46-25.05%
2013NZ$25.9721.73%
2012NZ$21.333.82%
2011NZ$20.558.16%
2010NZ$19.0023.72%
2009NZ$15.35-12.31%
2008NZ$17.51-0.34%
2007NZ$17.5732.13%
2006NZ$13.3042.56%
2005NZ$9.33-22.7%
2004NZ$12.07132.85%
2003NZ$5.18-149.3%
2002NZ-$10.51-209.09%
2001NZ$9.63-57.03%
2000NZ$22.4253.29%
1999NZ$14.6331.24%
1998NZ$11.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.29-57.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.29-65.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.29-93.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.32-82.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$25.35-29.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.48-87.48%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$9.56-73.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.23-82.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.80-80.98%๐Ÿ‡ฌ๐Ÿ‡ง UK